Echocardiographic markers of left ventricular dysfunction among men with uncontrolled hypertension and stage 3 chronic kidney disease

Medical Science Monitor

Volumn 19, Issue 1, 2013, Pages 838-845

  Grabysa, Radosław ^a   Wańkowicz, Zofia ^b  

^a MEDICA Healthcare Centre   (Poland)

^b MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Chronic kidney disease; Hypertension; Left ventricular dysfunction

Indexed keywords

CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; ECHOCARDIOGRAPHY; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; TRANSDUCER;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; BLOOD PRESSURE; ECHOCARDIOGRAPHY; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLAND; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84885352922     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.889586     Document Type: Article

References (45)

1. Kearney PM, Whelton M, Reynolds K et al: Worldwide prevalence of hypertension: a systematic review. J. Hypertens, 2004; 22: 11-19
2. Wolf-Maier K, Cooper RS, Kramer H et al: Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension, 2004; 43: 10-17
3. Fields LE, Burt VL, Butler JA et al: The burden of adult hypertension in the United States 1999 to 2000. A rising tide. Hypertension, 2004; 44: 398-404
4. Mancia G, De Backer G, Dominiczak A et al: 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Hypertension (ESH). J Hyperten, 2007; 25: 1105-87
5. Mancia G, Laurent S, Agabiti-Rosei E et al: Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens, 2009; 27: 2121-58
6. Olsen MH, Wachtell K, Bella JN et al: Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy. J Hum Hypertens, 2004; 18: 453-59
7. Devereux RB, Alonso D, Lutas EM et al: Echocardiographic assessment of left ventricular hypertrophy, comparison to necropsy findings. Am J Cardiol, 1986; 57: 450-55
8. Devereux RB, Wachtell K, Gerdts E: Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA, 2004; 292: 2350-56
9. NKF K/DOQI Clinical Practice Guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis, 2002; 39 (2, Suppl.1): S1-266
10. Stevens LA, Levey AS: Current status and future perspectives for CKD testing. Am J Kidney Dis, 2009; 53(Suppl.3): S17-26
11. Glassock RJ, Winearls C: An epidemic of chronic kidney disease: fact or fiction? Neprol Dial Transplant, 2008; 23: 1117-21
12. Levey AS, deJong PE, Coresh J et al: The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int, 2011; 80: 17-28
13. Go AS, Chertow GM, Fan D et al: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med, 2004; 351(13): 1296-305
14. Stengel B, Loury P, Froissart M et al: Long-term outcome in the elderly with chronic kidney disease (CKD) in the general population. Nephrol Dial Transplant, 2007; 22 (Suppl.6): vi226
15. Tokmakova MP, Skali H, Kenchaiah S et al: Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzume inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study. Circulation, 2004; 110(24): 3667-73
16. Hillege HL, Nitsch D, Pfeffer MA et al: Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation, 2006; 113(5): 671-78
17. National Collaborating Centre for Chronic Conditions. Chronic Kidney Disease: national clinical guideline for early identification and management in adults in primary and secondary care. London: Royal College of Physicians, September 2008
18. Crowe E, Halpin D, Stevens P: Early identification and management of chronic kidney disease: summary of NICE guidance. BMJ, 2008; 337: a1530
19. O'Brien E, Asmar R, Beilin L et al: European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens, 2003; 21: 821-48
20. De Simone G, Daniels SR, Devereux RB et al: Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and the impact of overweight. J Am Coll Cardiol, 1992; 20: 1251-60
21. Ganau A, Devereux RB, Roman MJ et al: Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol, 1992; 19: 1550-58
22. Schiller N Shah PM, Crawford M et al: Recommendations for quantification of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcomittee on Quantification of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr, 1989; 2: 358-67
23. Swedberg K, Cleland J, Dargie H et al: Task Force of the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur Heart J, 2005; 26: 1115-40
24. Thamm M: Blood pressure in Germany: current status and trends. Gesundheitwesen, 1999; 61: 90-93
25. Banegas JR, Rodriguez-Artalejo F, de la Cruz Troca JJ et al: Blood pressure in Spain: distribution, awareness, control, and benefits of a reduction in average pressure. Hypertension, 1998; 32: 998-1002
26. Zdrojewski T, Wyrzykowski B, Szczech R et al: Epidemiology and prevention of arterial hypertension in Poland. Blood Press Suppl, 2005; 2: 10-16
27. Grassi G, Cifkova R, Laurent S et al: Blood pressure and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study. Eur Heart J, 2011; 32: 218-25
28. Cea-Calvo L, Conthe P, Gomez-Fernandez P et al: Target damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study. Cardiovasc Diabetol, 2006; 5: 23
29. Mancia G, Carugo S, Grassi G et al: Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control. Data from the PAMELA population. Hypertension, 2002; 39: 744-49
30. Leoncini G, Viazzi F, Rosei EA et al: Chornic kidney disease in hypertension under specialist care: the I-DEMAND study. J. Hypertens, 2010; 28(1): 156-62
31. Leoncini G, Viazzi F, Parodi D et al: Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension. Hypertension, 2003; 42(1): 14-18
32. Levin A, Thompson C, Ethier J et al: Left ventricular mass index increase in early renal disease: impact in decline in haemoglobin. Am J Kidney Dis, 1999; 34: 125-34
33. Nardi E, Palermo A, Mule G et al: Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. J Hypertens, 2009; 27: 633-41
34. Tucker B, Fabbian F, Giles M et al: Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transplant, 1997; 12: 724-28
35. Paoletti E, Bellino D, Casottana P et al: Left ventricular hypertrophy in nondiabetic predialysis CKD. Am J Kidney Dis, 2007; 50: 1033-39
36. Levy D, Garrison RJ, Savage DD et al: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med, 1990; 322: 1561-66
37. Benjamin EJ, D'Agostino RB, Belanger AJ et al: Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation, 1992; 92: 835-41
38. Vasan RS, Larson MG, Benjamin EJ et al: Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med, 1997; 336: 1350-55
39. Eckardt K, Scherhag A, Macdougall IC et al: Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD. J Am Soc Nephrol, 2009; 20(12): 2651-60
40. London GM: Left ventricular alternation and end-stage renal disease. Nephrol Dial Transplant, 2002; 17: 29-36
41. Joki N, Hase H, Saijyo T et al: Combined assessment of cardiac systolic dysfunction and coronary atherosclerosis used to predict future cardiac deaths after starting hemodialysis. Am J Nephrol, 2003; 23: 458-65
42. Wu IW, Hung MJ, Chen YC et al: Ventricular function and all-cause mortality in chronic kidney disease patients with angiographic coronary artery disease. J Nephrol, 2010; 23: 181-88
43. Parker T, Hakim R, Nissenson AR et al: Dialysis at a crossroads. Clin J Am Soc Nephrol, 2011; 6: 457-61
44. Locattelli F, Canaud B: Dialysis adequacy today: a European perspective. Nephrol Dial Transplant, 2012; 27: 3043-48
45. KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl, 2013; 3(1): 1-50